• TOWA Pharmaceutical posted Q1 net sales of JPY 71.38 billion, up 9.6% year over year, with operating profit rising 25.2% to JPY 6.52 billion.
• Ordinary profit more than doubled to JPY 7.94 billion, helped by a JPY 1.42 billion gain on valuation of derivatives.
• Profit attributable to owners of parent more than doubled to JPY 5.53 billion, lifting earnings per share to JPY 112.36.
• Overseas segment profit swung to JPY 5 million from an operating loss, as net sales climbed 25% to JPY 15.61 billion.
• The company kept its full-year forecast for net sales at JPY 304 billion and operating profit at JPY 32 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOWA Pharmaceutical Co. Ltd. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.